Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease
(ILD) that occurs when susceptible individuals develop an exaggerated immune response to …

Challenges for the effective management of interstitial lung diseases (ILDs) include
difficulties with the early detection of disease, accurate prognostication with baseline data …

The incidental discovery of pre-clinical interstitial lung disease (ILD) has led to the
designation of interstitial lung abnormalities (ILA), a radiological entity defined as the …

Hypersensitivity pneumonitis is an immune‐mediated interstitial lung disease caused by an
aberrant response to an inhaled exposure, which results in mostly T cell–mediated …

Organizing pneumonia (OP), characterized histopathologically by patchy filling of alveoli
and bronchioles by loose plugs of connective tissue, may be seen in a variety of conditions …

Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary
fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific …

Interstitial lung disease (ILD) is a collective term representing a diverse group of pulmonary
fibrotic and inflammatory conditions. Due to the diversity of ILD conditions, paucity of …

Biological particles, along with inorganic gaseous and particulate pollutants, constitute an
ever-present component of the atmosphere and surfaces. Among these particles are fungal …

Rationale: Transbronchial cryobiopsy (TBCB) for the diagnosis of interstitial lung disease
(ILD) has shown promising results, but prospective studies with matched surgical lung …

Hypersensitivity pneumonitis (HP) is one of the most common interstitial lung diseases (ILD),
that presents unique challenges for a confident diagnosis and limited therapeutic options …